Processing your payment...
Please do not close your browser.

Breast Cancer Brachytherapy Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key Players: Eckert and Ziegler BEBIG, Elekta, ICAD, Hologic

31 Mar, 2022 | 119 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Acknowledging the kind of traction gained by this market, recently published a study report asserts the global Breast Cancer Brachytherapy Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 7.1% during the review period (2022 to 2027).



Breast Cancer Brachytherapy Market Overview



The growing prevalence of breast cancer is anticipated to accelerate market growth. According to the estimates of the American Cancer Society, in 2020, 279,240 new breast cancer cases were diagnosed and around 42,730 deaths are expected to occur in the U.S. alone. The presence of numerous non-profit organizations such as the National Breast Cancer Foundation, Inc., Indian Cancer Society, Breastcancer.org, and many others are expected to drive the market.



Increasing the adoption of breast HDR brachytherapy at hospitals and cancer care centers is expected to fuel segment growth. For instance, in November 2019, the SagiNova HDR afterloader system developed by Eckert and Ziegler BEBIG had extended its presence in various radiation oncology centers of Brazil after it received approval from Agência Nacional de Vigilância Sanitária (ANVISA).




Who are the Major Players in Breast Cancer Brachytherapy Market?



The global Breast Cancer Brachytherapy includes the identification and analysis of the various market participants competing in the global market. Prominent competitors include  Eckert and Ziegler BEBIG, Elekta, ICAD  Inc. (NasdaqCM :ICAD), Hologic , Inc. (NasdaqGS :HOLX), Varian Medical Systems, Cianna Medical and Others.



Industry News:



OCTOBER 2, 2018:Merit Medical (NSDQ:MMSI) agreed to acquire Cianna Medical and its breast cancer localization and guidance devices for up to $200 million.The Advanced Breast Template System for high-dose-rate (HDR) brachytherapy dramatically reduces treatment times and aids patient comfort. The Advanced Breast Template System is the first commercially manufactured template system for interstitial breast brachytherapy using multiple implantation techniques.



What are the major Applications, Types and Regions for Breast Cancer Brachytherapy Market?



By Type, it is segmented into




  • High-Dose Rate

  • Low-Dose Rate



By Application, it is segmented into




  • Medical Treatment

  • Biotechnology

  • Others



Breast Cancer Brachytherapy Market Regional Analysis



In North America, the market accounted for the largest revenue share of over 50.2% in 2019, owing to the presence of major players, increasing prevalence of the disease, established healthcare facilities, and high healthcare expenditure in the region. Moreover, the increasing adoption of brachytherapy over conventional methods for safer and more efficient breast cancer treatment is attributed to the highest share.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Breast Cancer Brachytherapy Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Breast Cancer Brachytherapy Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Breast Cancer Brachytherapy Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 7.1% during the review period (2022 to 2027).



By Type




  • High-Dose Rate

  • Low-Dose Rate



By Application




  • Medical Treatment

  • Biotechnology

  • Others



By Companies



Eckert and Ziegler BEBIG, Elekta, ICAD  Inc. (NasdaqCM :ICAD), Hologic , Inc. (NasdaqGS :HOLX), Varian Medical Systems, Cianna Medical and Others.



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



119



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this Breast Cancer Brachytherapy Report




  • Evaluate Breast Cancer Brachytherapy market potential through analyzing growth rates (CAGR %), Volume (Units), and Value ($M) data given at country level - for product types, end-use applications, and by different industries verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges, and hidden opportunities.

  • Get in-depth insights on your competitor's performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis, and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Breast Cancer Brachytherapy market entropy - M&As, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the import-export statistics, supply-demand, and competitive landscape for more than the top 20 countries globally for the market.



Frequently Asked Questions



What is the study period of this market?



The Breast Cancer Brachytherapy Market is studied from 2017 - 2027.



What is the growth rate of Breast Cancer Brachytherapy Market?



The Breast Cancer Brachytherapy Market is growing at a CAGR of 7.1% over the next 5 years.



Who are the leading key players in Breast Cancer Brachytherapy Market?



Eckert and Ziegler BEBIG, Elekta, ICAD  Inc. (NasdaqCM :ICAD), Hologic , Inc. (NasdaqGS :HOLX), Varian Medical Systems, Cianna Medical and Others.



What regions regions does this Breast Cancer Brachytherapy Market report covers?



North America (the United States, Canada, and Mexico)



Europe (Germany, France, UK, Russia, and Italy)



Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)



South America (Brazil, Argentina, Colombia, etc.)



The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)



What are the significant types of Breast Cancer Brachytherapy Market?



High-Dose Rate, Low-Dose Rate



What are the significant Applications of Breast Cancer Brachytherapy Market?



Medical Treatment, Biotechnology, Others



All our reports are custom made to your company's needs to a certain extent, we do provide 5 free consulting hours along with the purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINITION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMELINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL BREAST CANCER BRACHYTHERAPY MARKET BY TYPES

    3. GLOBAL BREAST CANCER BRACHYTHERAPY MARKET BY APPLICATION



  4. MARKET DYNAMICS

    1. DRIVERS

      1. INCREASING DEMAND FOR BREAST CANCER BRACHYTHERAPY



    2. RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGULATIONS

      2. HIGH COST OF MATERIALS



    3. OPPORTUNITIES

      1. BREAST CANCER BRACHYTHERAPY GROWTH

      2. APPLICATION OF BREAST CANCER BRACHYTHERAPY



    4. IMPACT OF COVID 19



  5. GLOBAL BREAST CANCER BRACHYTHERAPY MARKET, BY TYPES

    1. INTRODUCTION

    2. HIGH-DOSE RATE

    3. LOW-DOSE RATE



  6. GLOBAL BREAST CANCER BRACHYTHERAPY MARKET, BY APPLICATION

    1. INTRODUCTION

    2. MEDICAL TREATMENT

    3. BIOTECHNOLOGY

    4. OTHERS



  7. GLOBAL BREAST CANCER BRACHYTHERAPY MARKET, BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMANY

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1. ECKERT AND ZIEGLER BEBIG

      2. ELEKTA

      3. ICAD

      4. HOLOGIC

      5. VARIAN MEDICAL SYSTEMS

      6. CIANNA MEDICAL





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 9
  • 3M